Anthrax drug brings $334 million to Pentagon advisor's biotech firm

May 20, 2013 1:43 AM

48 0

Biowarfare consultant Richard J. Danzig urged the government to stockpile a type of anthrax remedy. But he had a stake in one such drug's success.

The mailing of anthrax-laced letters to congressional leaders and news organizations in 2001 sparked fears of further biological attacks. Above, office buildings on Capitol Hill had to be decontaminated. (Ron Thomas / Associated Press)

Read more

To category page